Acetylsalicylic acid (aspirin) for schizophrenia-Reference-Cited by-同舟云学术

Acetylsalicylic acid (aspirin) for schizophrenia

Published:2019-08-10 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Schmidt Lena¹,Phelps Emma²,Friedel Johannes³,Shokraneh Farhad⁴

Affiliation:

1. University of Bristol; Bristol Medical School; 39 Whatley Road Bristol UK BS8 2PL

2. Institute of Mental Health, University of Nottingham; Jubilee Campus, University of Nottingham Innovation Park, Triumph Road Nottingham UK NG7 2TU

3. Hochschule Furtwangen University; Furtwangen Germany

4. University of Nottingham; Cochrane Schizophrenia Group, Institute of Mental Health, Division of Psychiatry and Applied Psychology, School of Medicine; Nottingham UK NG7 2TU

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012116.pub2/epdf/full

Reference70 articles.

1. Aspirin inclusion in antipsychotic treatment on severity of symptoms in schizophrenia: a randomized clinical trial;Attari;Iranian Journal of Psychiatry and Behavioral Sciences,2017

2. Burger H Acetylsalicylic acid as an adjuvant therapy for schizophrenia www.isrctn.com

3. Burger H Acetylsalicylic acid for schizophrenia Stanley Foundation Research Programs 2009

4. Adjunct aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial;Laan;Journal of Clinical Psychiatry,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration on the potential efficacy and mechanism of methyl salicylate glycosides in the treatment of schizophrenia based on bioinformatics, molecular docking and dynamics simulation;Schizophrenia;2024-07-17

2. Perspective Chapter: Aspirin – The Wonder Drug;Pharmaceutical Science;2024-02-07

3. A double-blind, randomized controlled study of the effects of celecoxib on clinical symptoms and cognitive impairment in patients with drug-naïve first episode schizophrenia: pharmacogenetic impact of cyclooxygenase-2 functional polymorphisms;Neuropsychopharmacology;2023-10-30

4. Salicylic Acid: Synthetic Strategies and Their Biological Activities;ChemistrySelect;2023-04-03

5. MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets;Neuroscience & Biobehavioral Reviews;2023-03